Costs and Expenses in USD of Coherus BioSciences, Inc. from 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Coherus BioSciences, Inc. quarterly/annual Costs and Expenses history and growth rate from 2018 to Q3 2025.
  • Coherus BioSciences, Inc. Costs and Expenses for the quarter ending September 30, 2025 was $55.9M, a 5.66% increase year-over-year.
  • Coherus BioSciences, Inc. Costs and Expenses for the twelve months ending September 30, 2025 was $218M, a 142% increase year-over-year.
  • Coherus BioSciences, Inc. annual Costs and Expenses for 2024 was $226M, a 4.16% increase from 2023.
  • Coherus BioSciences, Inc. annual Costs and Expenses for 2023 was $217M, a 53.6% decline from 2022.
  • Coherus BioSciences, Inc. annual Costs and Expenses for 2022 was $468M, a 20.7% decline from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)

Coherus BioSciences, Inc. Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $218M $55.9M +$3M +5.66% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $215M $55.7M +$5.82M +11.7% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $209M $53M -$17.1M -24.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $226M $53.1M +$136M Oct 1, 2024 Dec 31, 2024 8-K 2025-11-13
Q3 2024 $89.9M $52.9M -$53.7M -50.4% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $144M $49.9M -$43.3M -46.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $187M $70.1M -$30.1M -30% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 $217M -$83M -$180M -186% Oct 1, 2023 Dec 31, 2023 8-K 2025-11-13
Q3 2023 $397M $107M -$19.3M -15.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $416M $93.3M -$10.9M -10.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $427M $100M -$40.9M -29% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $468M $96.8M -$16.1M -14.2% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-17
Q3 2022 $484M $126M +$10.6M +9.18% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $473M $104M -$7.64M -6.84% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $481M $141M -$109M -43.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $590M $113M +$18.9M +20.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 $571M $115M +$35.5M +44.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $536M $112M +$41.4M +58.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $495M $250M +$175M +232% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $320M $94M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $79.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $70.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $75.3M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06

Coherus BioSciences, Inc. Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $226M +$9.04M +4.16% Jan 1, 2024 Dec 31, 2024 8-K 2025-11-13
2023 $217M -$251M -53.6% Jan 1, 2023 Dec 31, 2023 8-K 2025-11-13
2022 $468M -$122M -20.7% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-17
2021 $590M +$271M +84.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 $320M +$71.2M +28.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 $248M +$43.9M +21.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 $204M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.